InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

INM

Insider Sentiment (TTM):

Last Purchase:2026-06-08Last Sale:2024-07-31Shares Purchased (TTM):501,051Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:299,340Shares Outstanding:4,048,209Institutional Ownership Pct.:7.39%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31	2023-09-30	2023-06-30
Cash And Cash Equivalents At Carrying Value	5	7	9	11	5	3	6	7	10	7	9
Short Term Investments	0	0	0	0	0	0	0	0	0	0	0
Accounts Receivable Net Current	-	0	0	0	0	0	0	0	0	0	0
Assets Current
Assets Current	7	9	11	13	6	5	7	9	12	8	11
Inventory Net	-	1	1	1	1	1	1	1	1	1	2
Prepaid Expense And Other Assets Current	1	1	0	0	1	1	0	0	1	0	0
Assets Of Disposal Group Including Discontinued Op…	1	-	-	-	-	-	-	-	-	-	-
Assets Noncurrent
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	1	1
Intangible Assets Net Excluding Goodwill	1	2	2	2	2	2	2	2	2	2	2
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0
Assets	9	11	13	16	9	9	10	12	15	11	14
Accounts Payable And Accrued Liabilities Current	1	1	1	1	1	1	1	2	1	1	2
Liabilities Current
Liabilities Current	2	1	2	2	2	2	1	2	2	1	2
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0
Deferred Rent Credit Current	-	-	-	-	-	-	-	-	0	-	0
Liabilities Of Disposal Group Including Discontinu…	1	-	-	-	-	-	-	-	-	-	-
Liabilities Noncurrent
Operating Lease Liability Noncurrent	0	0	0	0	0	1	1	1	1	-	0
Liabilities	2	2	2	2	2	2	2	3	2	1	2
Common Stock Value	93	92	92	91	87	85	84	83	80	78	78
Additional Paid In Capital Common Stock	38	38	39	39	35	35	35	35	38	36	36
Stockholders Equity
Stockholders Equity	7	10	12	13	7	6	8	9	13	-10	12
Retained Earnings Accumulated Deficit	-124	-121	-119	-117	-115	-113	-111	-109	-105	-104	-101
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	0	0
Liabilities And Stockholders Equity	9	11	13	16	9	9	10	12	15	11	14
Accounts Receivable Net	-	-	-	-	-	-	-	-	-	-	0
Allowance For Doubtful Accounts Receivable Current	-	-	-	0	-	-	-	-	-	-	-
Common Stock Shares Issued	3	3	3	2	1	1	1	0	0	0	0
Shares Outstanding	3	3	3	2	1	1	1	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-21.99%	-28.45%	-34.90%	-7.07%	-31.52%	-27.78%	116.25%	112.12%	135.54%	-	-	-
2025	8.27%	-2.17%	-39.37%	-14.69%	-41.88%	-3.59%	25.88%	27.63%	4.82%	-1.87%	-20.33%	-33.18%
2024	3.63%	-4.15%	-6.22%	-1.69%	-9.55%	-32.02%	-	-	-	40.51%	-1.69%	-7.19%
2023	-	-	-	-	-	-	12.07%	-16.81%	-12.07%	-16.00%	-35.43%	-48.57%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.11	5.94	6.95	6.99	3.49	3.05	5.07	4.41	7.03	6.19	5.66
Quick Ratio	2.84	4.85	6.25	6.30	2.77	2.08	4.12	3.53	5.92	5.19	4.61
Working Capital	4.68M	7.31M	9.24M	11.03M	4.57M	3.68M	5.84M	6.72M	10.13M	6.96M	9.33M
Leverage & Debt
Debt to Equity	0.33	0.17	0.15	0.16	0.32	0.38	0.25	0.28	0.19	-0.14	0.17
Interest Coverage TTM	-	-	-	-	-	-	-	-	-4,233.23	-1,548.83	-702.93
Debt Ratio	0.25	0.14	0.13	0.14	0.24	0.27	0.20	0.22	0.16	0.12	0.14
Efficiency & Turnover
Asset Turnover TTM	0.35	0.46	0.40	0.36	0.30	0.37	0.28	0.34	0.34	0.37	0.31
Days Sales Outstanding TTM	-	18.04	23.89	30.20	37.16	21.62	29.20	21.44	15.12	7.00	15.38
Receivables Turnover TTM	-	20.23	15.28	12.09	9.82	16.88	12.50	17.02	24.14	52.11	23.74
Per Share Metrics
Diluted EPS TTM	-2.10	-1.94	-2.08	-8.36	-5.82	-8.11	-9.18	-11.42	-15.93	-41.91	-64.92
Free Cash Flow Per Share TTM	-1.84	-1.88	-1.91	-7.96	-5.46	-8.76	-9.45	-12.31	-15.92	-43.28	-59.49
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	29.73%	33.69%	34.53%	-	-	-	-	38.42%	40.61%	33.93%
Operating Profit Margin TTM	-258.52%	-170.07%	-171.13%	-165.14%	-173.72%	-158.47%	-167.11%	-97.72%	-115.69%	-147.73%	-191.86%
Net Profit Margin TTM	-262.24%	-170.07%	-171.13%	-165.14%	-175.20%	-158.47%	-167.11%	-97.76%	-115.75%	-147.86%	-192.18%
Growth Metrics
Net Revenue Growth (1Y)	-10.80%	24.61%	40.84%	10.99%	-33.70%	-23.32%	-17.62%	90.37%	239.77%	234.46%	279.61%
Net Income Growth (1Y)	33.51%	33.73%	44.24%	87.49%	0.35%	-17.83%	-28.37%	-71.88%	-62.54%	-63.56%	-57.27%
EPS Growth (1Y)	-63.85%	-76.11%	-77.38%	-26.80%	-63.50%	-80.65%	-85.86%	-87.72%	-89.19%	-90.52%	-90.21%
Valuation Metrics
P/E TTM	-0.31	-0.55	-1.05	-0.39	-0.36	-0.58	-0.52	-0.47	-0.52	-0.33	-0.29
P/B TTM	0.38	0.44	0.75	0.24	0.32	0.54	0.35	0.22	0.26	-0.24	0.19
P/S TTM	0.80	0.93	1.80	0.64	0.62	0.93	0.86	0.46	0.60	0.49	0.55
Market Cap	2.61M	4.19M	8.66M	3.17M	2.27M	3.35M	2.94M	2.03M	3.32M	2.33M	2.27M
Enterprise Value	-2.55M	-2.76M	-670.61K	5.78M	-2.41M	-70.39K	-2.64M	-4.54M	-6.22M	-4.41M	-6.64M
Calculated Values
Free Cash Flow TTM	-7.46M	-7.42M	-7.55M	-7.77M	-5.99M	-6.19M	-5.86M	-4.69M	-6.35M	-7.20M	-7.28M
Net Debt	-5.16M	-6.95M	-9.33M	2.61M	-4.68M	-3.42M	-5.58M	-6.57M	-9.53M	-6.74M	-8.91M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-08Purchase

Owner: Vivo, Opportunity, Llc, V…

Title: -

Shares: 32,500

Price/Share: $1.52

Value: $49,400.00

Shares Owned: 718,444

Relationship: TenPercentOwner

Ownership: Indirect

2026-05-19Purchase

Owner: Schneeberger, Daniel, Ada…

Title: -

Shares: 468,551

Price/Share: $1.55

Value: $726,254.05

Shares Owned: 800,000

Relationship: TenPercentOwner

Ownership: Indirect

2024-07-31Sale

Owner: Mancini, Alexandra Diane …

Title: -

Shares: 240

Price/Share: $0.18

Value: $43.20

Shares Owned: -

Relationship: Other

Ownership: Direct

2024-02-21Purchase

Owner: Hull, Andrew

Title: -

Shares: 37,500

Price/Share: $0.39

Value: $14,625.00

Shares Owned: 38,258

Relationship: Director

Ownership: Direct

2024-02-20Purchase

Owner: Adams, Eric A

Title: President & CEO

Shares: 41,600

Price/Share: $0.36

Value: $14,976.00

Shares Owned: 43,959

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-08	Vivo, Opportunity, Llc, V…	TenPercentOwner	-	Indirect	Purchase	32,500	1.52	$49,400.00	718,444	4
2026-05-19	Schneeberger, Daniel, Ada…	TenPercentOwner	-	Indirect	Purchase	468,551	1.55	$726,254.05	800,000	4
2024-07-31	Mancini, Alexandra Diane …	Other	-	Direct	Sale	240	0.18	$43.20	0	4
2024-02-21	Hull, Andrew	Director	-	Direct	Purchase	37,500	0.39	$14,625.00	38,258	4
2024-02-20	Adams, Eric A	Director,Officer	President & CEO	Direct	Purchase	41,600	0.36	$14,976.00	43,959	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

7.39%

Inst. Shares: 299,340

Shares Outstanding: 4,048,209

2025-12-31

5.74%

Inst. Shares: 227,042

Shares Outstanding: 3,954,549

2025-09-30

7.16%

Inst. Shares: 283,234

Shares Outstanding: 3,954,549

2025-06-30

0.87%

Inst. Shares: 8,464

Shares Outstanding: 975,985

2025-03-31

0.58%

Inst. Shares: 6,408

Shares Outstanding: 1,095,973

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	299,340	4,048,209	7.39%
2025-12-31	227,042	3,954,549	5.74%
2025-09-30	283,234	3,954,549	7.16%
2025-06-30	8,464	975,985	0.87%
2025-03-31	6,408	1,095,973	0.58%
2024-12-31	48,897	706,546	6.92%
2024-09-30	1,075,145	620,127	173.37%
2024-06-30	337,570	381,053	88.59%
2024-03-31	657,594	398,673	164.95%
2023-12-31	765,369	398,673	191.98%
2023-09-30	26,848	166,410	16.13%
2023-06-30	15,631	122,423	12.77%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

InMed Pharmaceuticals Inc. (INM) — SEC Financial Statements & Analysis

InMed Pharmaceuticals Inc. (INM) is a pharmaceutical preparations company, incorporated in A1. InMed Pharmaceuticals Inc. trades on Nasdaq as: INM. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), InMed Pharmaceuticals Inc. reported a -10.80% year-over-year revenue growth, a Gross Profit Margin of 29.73% (TTM), a Debt-to-Equity ratio of 0.33x, a Price-to-Sales (P/S) ratio of 0.80x (TTM), a Price-to-Book (P/B) ratio of 0.38x (TTM), at a market cap of $2.61M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -10.80%
Gross Profit Margin TTM: 29.73%
Debt To Equity: 0.33x
P/S TTM: 0.80x
P/B TTM: 0.38x
Market Cap: $2.61M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is InMed Pharmaceuticals Inc. in?

InMed Pharmaceuticals Inc. (INM) operates in the Pharmaceutical Preparations industry.

What is INM's market cap?

InMed Pharmaceuticals Inc. (INM) has a market capitalization of $2.61M as of 2026-03-31.

What exchange does INM trade on?

InMed Pharmaceuticals Inc. (INM) trades on the Nasdaq.

Where is InMed Pharmaceuticals Inc. incorporated?

InMed Pharmaceuticals Inc. is incorporated in British Columbia, Canada.